Background:
Atrial fibrillation (AF) is the most frequent sustained
arrhythmia. The prevalence is increasing with that of other cardiovascular risk
factors in our low-income setting. It is potentially serious due to the
associated complications. Few data exist on the epidemiology of AF in
Sub-Saharan Africa (SSA). Methodology: We carried out a cross-sectional study
between 2005 and 2009 in the Cardiology Unit of the Douala General Hospital.
Patients were adults ≥ 18 years of both sex, who had an ECG diagnosis of Atrial
Fibrillation and a comprehensive investigation of the cause of AF. Results: A
total of 2581 patients were seen in this unit, of whom 182 (7.1%, [95%: 6.1-8.1]) had AF. Their mean age was 59.2 ± 15.4 years,
and there were 100 (58.2%, [95% CI: 51-65.6], p = 0.002) females. Hypertension was the most frequent risk factor
(77.3%, [95% CI: 70.3-82.8]), and 163 (95.3%, [95% CI: 90.7-97.8]) of the
patients were symptomatic. Hypertensive heart disease (45.6%, [95% CI: 38.3-53.1]), idiopathic dilated cardiomyopathy (19.3%, [95% CI: 14.1-25.9]), and
valvular heart disease (16.4%, [95% CI: 11.6-22.6]) were the main etiologic
factors of AF. The most frequent complications were heart failure seen in 77
(45%, [37.8-52.5]) and ischemic stroke in 27 (15.5%, [95% CI: 11.1 - 22]) of
patients. Digoxine was prescribed in 121 (70.8%, [95% CI: 63.6-77.1]) patients
to control heart rate, while amiodarone was prescribed in 67 (29.2%, [95% CI:
32.2-46.7]) patients to revert to sinus rhythm. No electrical cardioversion
was carried out. Aspirine was prescribed in 119 (69.6%, [95% CI: 62.3-76])
patients, and anti-vitamin K in 53 (30.4%, [95% CI: 24.5-38.3]) patients. Conclusion:
Atrial fibrillation was seen in seven percent of patients in the Cardiology Unit of this low-income setting.
Patients were relatively young compared with high income settings. Hypertension, idiopathic
dilated cardiomyopathy, and valvular heart disease were the main causes. Rate
control was the main treatment strategy. Oral anti-coagulants were less
frequently used.
Cite this paper
Kamdem, F. , Hamadou, B. , Kamdem, M. , Nganou, C. N. , Dzudie, A. , Monkam, Y. and Kingue, S. (2017). Epidemiologic Aspects of Atrial Fibrillation in a Tertiary Hospital in a Sub-Saharan Africa Setting. Open Access Library Journal, 4, e3384. doi: http://dx.doi.org/10.4236/oalib.1103384.
Bonita, R., Reddy, S., Galbraith, S., et al. (2003) Neglected Global Epidemics: Three Growing Threats: The World Health Report 2003—Shaping the Future. WHO, Geneva, 83-102.
Reddy, K.S. and Yusuf, S. (1998) Emerging Epidemic of Cardiovascular Disease in Developing Countries. Circulation, 97, 596-601.
https://doi.org/10.1161/01.CIR.97.6.596
Bjorck, S., Palaszewski, B., Friberg, L. and Bergfeldt, L. (2013) Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study. Stroke, 44, 3103-3108.
https://doi.org/10.1161/STROKEAHA.113.002329
Haim, M., Hoshen, M., Reges, O., Rabi, Y., Balicer, R. and Leibowitz, M. (2015) Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients with Incident Non-Valvular Atrial Fibrillation. Journal of the American Heart Association, 4, e001486.
https://doi.org/10.1161/jaha.114.001486
Stewart, S., Hart, C.L., Hole, D.J. and McMurray, J.J. (2002) A Population-Based Study of the Longterm Risks Associated with Atrial Fibrillation: 20-Year Follow-Up of the Renfrew/Paisley Study. The American Journal of Medicine, 113, 359-364.
https://doi.org/10.1016/S0002-9343(02)01236-6
Wolf, P.A., Abbott, R.D. and Kannel, W.B. (1999) Atrial Fibrillation as an Independent Risk Factor for Stroke: The Framingham Study. Stroke, 22, 983-988.
https://doi.org/10.1161/01.STR.22.8.983
Krahn, A.D., Manfreda, J., Tate, R.B., Mathewson, F.A. and Cuddy, T.E. (1995) The Natural History of Atrial Fibrillation: Incidence, Risk Factors, and Prognosis in the Manitoba Follow-Up Study. The American Journal of Medicine, 98, 476-484.
https://doi.org/10.1016/S0002-9343(99)80348-9
Lévy, S., Maarek, M. and Coumel, P.H. (1999) On Behalf or the College of French Cardiologists. Characterization of Different Subsets of Atrial Fibrillation in General Practice in France. The ALFA Study. Circulation, 99, 3028-3035.
https://doi.org/10.1161/01.CIR.99.23.3028
Mbaye, A., Pessiniba, S., Bodian, M.L., et al. (2010) Frequency, Etiologic Factors, Evolution, and Treatment in a Cardiology Service in Dakar. The Pan African Medical Journal, 6, 16.
Longo, M.B. and Milamba, K.Y. (1993) Epidemiologic and Electrocardiographic Aspects of Atrial Fibrillation in Adults in Congo-Zaire. L’Information Cardiologique, 17, 227-232.
Ntep-Gweth, M., et al. (2010) Atrial Fibrillation in Africa: Clinical Characteristics, Prognosis, and Adherence to Guidelines in CAMEROON. Europace, 12, 482-487.
https://doi.org/10.1093/europace/euq006
De Vos, C.B., Pisters, R., Nieuwlaat, R., et al. (2010) Progression from Paroxysmal to Persistent Atrial Fibrillation: Clinical Correlates and Prognosis. Journal of the American College of Cardiology, 55, 725-731.
https://doi.org/10.1016/j.jacc.2009.11.040
Nieuwlaat, R., Capucci, A., Camm, A.J., et al. (2005) Atrial Fibrillation Management: A Prospective survey in ESC Member Countries: The Euro Heart Survey on Atrial Fibrillation. European Heart Journal, 26, 2422-2434.
https://doi.org/10.1093/eurheartj/ehi505
Coulibaly, I., Anzouan-Kacou, J.B., Konin, C., et al. (2010) Epidemiology and Associated Cardiopathy in the Cardiology Institute of Abidjan. Cardiovascular Journal of Africa, 2, S4-S12.